We previously reported that multidrug-resistant (MDR) human cancer cells were significantly more resistant to Hsp90 inhibitors than their parental drug sensitive cells, and resistance to Hsp90 inhibitors in MDR cells could be overcome through down-regulation of Hsps and P-gp [19]. The gene discussed is PGP; the disease is cancer.